Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
Metastatic uveal melanoma (mUM) is an advanced ocular malignancy characterized by a hepatotropic pattern of spread. As the incidence of brain metastases (BM) in mUM patients has been thought to be low, routine CNS surveillance has not been recommended. Notably, no formal assessment of BM incidence i...
Main Authors: | Alexander Z. Wei, Matan Uriel, Agata Porcu, Michael P. Manos, Ann C. Mercurio, Michael M. Caplan, Liam Hulse, Rino S. Seedor, Marta Holovatska, Jasmine Francis, Shaheer A. Khan, Diana E. McDonnell, Dmitry Bogomolny, Takami Sato, Brian P. Marr, Rizwan Haq, Marlana Orloff, Alexander Shoushtari, Richard D. Carvajal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.961517/full |
Similar Items
-
Genetic Landscape and Emerging Therapies in Uveal Melanoma
by: Rino S. Seedor, et al.
Published: (2021-11-01) -
Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016)
by: Asad Loya, et al.
Published: (2022-03-01) -
Posterior uveal melanoma in adolescents and children: current perspectives
by: Fry MV, et al.
Published: (2018-11-01) -
Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes
by: Charlotte Andrieu, et al.
Published: (2022-05-01) -
Experimental Models for Rare Melanoma Research—The Niche That Needs to Be Addressed
by: Ioana Ionita, et al.
Published: (2023-06-01)